0,1,2,3,4,5,6,7
,,,,,,,TLR2
,,Time post-infection (min),,,,,
,,,,,,siRNA treatment,
(d),,P-p38MAPK,,(h),IL-6,,
,,,,Control,,,
120,,,,200,,,
,,***,Pam3CSK4,MHV3,,,
100,,,MHV3,,,,
,,,,160,,,
,,,,,**,**,**
,,,MHV-A59,,,,
80,***,,,,,,
,,**,,120,,,
"P-p38/p38 Total (%)
60",,,,IL-6 (pg/ml),,,
,**,,,,,,
,,,,80,,,
40,,,,,,,
,,,*,,,,
,,,,40,,,
20,,,,,,,
,,,,0,,,
